background
studi
aim
determin
preval
respiratori
pathogen
among
newborn
admit
neonat
medium
care
unit
nmcu
identifi
clinic
predictor
method
observ
studi
perform
neonat
admit
nmcu
amsterdam
netherland
nasopharyng
sampl
collect
detect
respiratori
virus
bacteria
realtim
pcr
rtpcr
cycl
threshold
ct
valu
provid
estim
viral
load
predictor
presenc
studi
pathogen
identifi
result
octob
septemb
neonat
median
age
male
includ
overal
respiratori
pathogen
detect
children
n
human
rhinoviru
n
n
respiratori
syncyti
viru
rsv
n
streptococcu
pneumonia
n
adenoviru
n
human
coronaviru
n
influenza
n
bocaviru
n
neonat
higher
viral
load
ct
n
often
clinic
ill
lower
viral
load
ct
n
two
variabl
significantli
contribut
detect
studi
pathogen
age
odd
ratio
day
older
confid
interv
rhinorrhea
confid
interv
conclus
respiratori
pathogen
seem
play
role
neonat
admit
nmcu
influenc
respiratori
pathogen
detect
clinic
manag
remain
determin
male
sex
n
age
day
mean
rang
ethnic
caucasian
n
mediterranean
n
n
admiss
h
postpartum
n
durat
admiss
day
median
iqr
pregnanc
deliveri
characterist
pregnanc
durat
day
mean
sd
first
gravid
n
birth
weight
g
mean
sd
preterm
deliveri
wk
n
cesarean
section
n
epidur
anesthesia
n
pregnanc
deliveri
complic
matern
fever
deliveri
n
prolong
ruptur
membran
h
n
group
b
streptococcu
colon
n
antibiot
treatmentprophylaxi
nn
present
symptom
dyspnea
n
nasal
flare
n
rhinorrhea
n
wheez
n
nfection
neonat
newborn
children
age
postpartum
known
caus
signific
mortal
longterm
morbid
one
import
infecti
diseas
syndrom
newborn
neonat
sepsi
estim
incid
first
h
life
infant
sepsi
present
nonspecif
sign
symptom
common
vagu
sign
temperatur
instabl
lethargi
apnea
poor
feed
neonat
respiratori
tract
infect
present
clinic
pictur
consist
sepsi
addit
classic
symptom
tachypnea
hypoxemia
outcom
neonat
infect
may
improv
ill
recogn
earli
appropri
antimicrobi
agent
administ
promptli
sepsi
reason
exclud
clinic
ground
blood
cultur
obtain
empir
antibiot
administ
unfortun
laboratori
investig
alway
help
cultur
blood
tissu
often
neg
possibl
perform
earli
detect
viral
respiratori
tract
infect
could
use
might
reduc
use
antibiot
common
pathogen
caus
respiratori
ill
newborn
respiratori
syncyti
viru
rsv
influenza
viru
adenoviru
rhinoviru
parainfluenza
virus
less
common
pathogen
includ
recent
identifi
bocaviru
also
detect
infant
acut
respiratori
infect
howev
preval
infect
respiratori
pathogen
neonat
therefor
extent
clinic
problem
fragil
pediatr
popul
remain
larg
unknown
therefor
aim
determin
preval
respiratori
pathogen
virus
bacteria
among
popul
neonat
admit
neonat
medium
care
unit
nmcu
period
secondari
object
compar
clinic
cours
neonat
without
respiratori
pathogen
identifi
risk
factor
predictor
presenc
pathogen
octob
septemb
total
neonat
admit
nmcu
hospit
screen
nasopharyng
aspir
presenc
respiratori
pathogen
median
age
hospit
male
median
durat
admiss
eightyeight
children
deliv
preterm
ie
wk
born
prolong
ruptur
membran
ie
h
three
hundr
nine
neonat
admit
nmcu
within
h
birth
almost
exclus
admit
articl
smit
et
al
hospit
labor
deliveri
remain
mostli
transfer
home
hospit
undifferenti
perinat
infect
ie
perinat
infect
unknown
origin
diagnos
newborn
wherea
diagnosi
perinat
sepsi
establish
antibiot
given
relev
characterist
summar
tabl
note
specif
diagnosi
ie
infect
diagnosi
made
neonat
admiss
remain
neonat
mere
clinic
observ
prematur
age
n
deliveri
complic
n
prolong
ruptur
membran
cesarean
section
assist
vagin
deliveri
matern
fever
deliveri
display
tabl
perform
blood
cultur
posit
bacteri
pathogen
follow
bacteria
cultur
staphylococcu
aureu
n
staphylococcu
epidermidi
n
micrococcu
lyla
n
escherichia
coli
n
streptococcu
sangui
n
staphylococcu
capiti
n
detail
regard
antibiot
durat
type
shown
extend
cours
antibiot
ie
administ
neonat
receiv
antibiot
treatment
antibiot
treatment
guid
local
protocol
initi
antibiot
treatment
case
presum
sepsi
undifferenti
perinat
infect
consist
amoxicillin
combin
gentamicin
follow
switch
gentamicin
cefotaxim
antibiot
treatment
continu
case
diagnosi
mening
consid
flucloxacillin
ad
abovement
regimen
antibiot
use
case
communityacquir
pneumonia
amoxicillin
cefotaxim
use
pneumonia
hospit
acquir
choic
antibiot
use
guid
result
avail
posit
microbiolog
cultur
report
tabl
demonstr
studi
pathogen
identifi
via
realtim
pcr
rtpcr
nasopharyng
aspir
newborn
children
admit
studi
period
nmcu
depart
hospit
overal
pathogen
detect
children
compris
total
popul
mean
cycl
threshold
ct
valu
posit
sampl
sd
twentyon
percent
studi
pathogen
identifi
month
decemb
parainfluenza
virus
detect
posit
sampl
regard
entir
studi
period
n
human
rhinoviru
n
n
rsv
n
frequent
detect
human
rhinoviru
frequent
detect
pathogen
octob
three
four
instanc
parainfluenza
virus
compris
almost
half
identifi
pathogen
novemb
decemb
rsv
show
peak
activ
januari
four
six
although
streptococcu
pneumonia
n
detect
bacteri
pathogen
rtpcr
blood
cultur
remain
neg
influenza
b
human
metapneumoviru
chlamydia
pneumonia
mycoplasma
pneumonia
legionella
speci
detect
two
coronavirus
detect
human
coronaviru
simultan
presenc
two
pathogen
observ
three
children
posit
rsv
combin
either
human
rhinoviru
human
coronaviru
pneumonia
demograph
clinic
characterist
tabl
compar
neonat
rtpcr
posit
studi
pathogen
n
neg
rtpcr
result
n
univari
analysi
identifi
seven
statist
signific
p
predictor
variabl
age
late
newborn
admiss
h
postpartum
first
gravid
preterm
deliveri
wk
epidur
anesthesia
rhinorrhea
wheez
subsequ
ad
logist
regress
model
see
tabl
statist
addit
signific
contribut
variabl
nonsignific
differ
compar
rtpcrposit
rtpcrneg
group
observ
regard
variabl
male
sex
vs
p
median
durat
admiss
vs
p
mean
birth
weight
gram
vs
gram
p
mean
leukocyt
count
l
vs
l
p
remain
characterist
tabl
compar
two
group
includ
diagnosi
undifferenti
perinat
infect
vs
pneumonia
vs
posit
blood
cultur
result
n
restrict
group
neonat
nasopharyng
sampl
rtpcrneg
studi
pathogen
explor
possibl
associ
amount
viru
detect
posit
sampl
certain
clinic
characterist
arbitrari
cutoff
ct
valu
use
compar
neonat
higher
viral
load
ct
n
lower
viral
load
ct
n
neonat
posit
sampl
contain
higher
viru
concentr
older
mean
age
vs
p
suffer
rsv
infect
take
seriou
cours
neonat
specif
compar
clinic
cours
neonat
rtpcrconfirm
rsv
infect
n
posit
result
pathogen
n
found
durat
admiss
significantli
longer
among
rsv
infect
median
durat
vs
p
variabl
relat
clinic
cours
antibiot
therapi
oxygen
supplement
ventilatori
support
differ
group
likewis
compar
clinic
cours
neonat
rtpcrconfirm
dual
infect
n
mono
infect
n
although
dualinfect
children
significantli
nasal
flare
vs
p
intersubcost
retract
vs
p
abnorm
lung
auscult
sound
vs
p
relev
variabl
relat
clinic
outcom
eg
durat
admiss
ill
sever
eg
vital
sign
compar
group
furthermor
none
dualinfect
neonat
need
oxygen
supplement
invas
respiratori
assist
addit
compar
variabl
neonat
without
posit
rtpcr
studi
pathogen
anoth
comparison
made
base
present
sign
respiratori
infect
dyspnea
nasal
flare
rhinorrhea
wheez
neonat
respiratori
symptom
posit
rtpcr
wherea
neonat
without
respiratori
symptom
posit
rtpcr
differ
proport
statist
signific
p
compar
neonat
specif
diagnosi
made
hospit
stay
n
mere
observ
clinic
n
differ
rtpcr
posit
rate
statist
signific
vs
p
neonat
requir
continu
posit
airway
pressur
n
two
posit
studi
pathogen
none
requir
mechan
ventil
n
posit
rtpcr
tabl
summar
result
logist
regress
analysi
odd
ratio
or
calcul
adjust
age
sex
estim
risk
posit
rtpcr
studi
pathogen
per
includ
variabl
adjust
two
variabl
identifi
signific
contributor
model
age
day
older
confid
interv
symptom
rhinorrhea
confid
interv
rhinorrhea
calcul
predict
characterist
symptom
within
popul
determin
posit
predict
valu
neg
predict
valu
prospect
observ
studi
describ
popul
neonat
admit
nmcu
hospit
period
octob
septemb
respiratori
pathogen
detect
rtpcr
nasopharyng
aspir
total
newborn
children
n
human
rhinoviru
n
n
rsv
n
frequent
detect
knowledg
first
studi
determin
preval
respiratori
pathogen
among
neonat
admit
medium
care
unit
studi
neonat
perform
neonat
intens
care
unit
therefor
entir
compar
medium
care
unit
popul
gener
consid
milder
neonat
patient
categori
moreov
studi
sole
use
immunofluoresc
andor
cultur
rang
studi
respiratori
pathogen
differ
less
extens
studi
even
less
compar
studi
focus
select
pediatr
popul
older
children
age
acut
respiratori
infect
studi
popul
parainfluenza
viru
identifi
pathogen
detect
pathogen
wherea
studi
common
rsv
frequent
detect
viru
rsv
account
detect
pathogen
studi
besid
studi
popul
entir
compar
anoth
explan
discrep
might
fact
notic
milder
usual
rsv
epidem
winter
among
children
hospit
gener
rtpcr
use
diagnost
method
studi
oppos
neonat
studi
studi
compar
multiplex
pcr
assay
convent
techniqu
diagnos
respiratori
viru
infect
children
admit
hospit
acut
respiratori
ill
pcr
sensit
advantag
shorter
delay
specif
diagnosi
lower
cost
immunofluoresc
cultur
anoth
studi
conclud
rtpcr
respiratori
virus
found
sensit
reliabl
method
pediatr
intens
care
unit
patient
lower
respiratori
tract
infect
twofold
increas
diagnost
yield
compar
convent
method
howev
limit
use
pcr
assay
acknowledg
studi
show
asymptomat
carriag
respiratori
viru
occur
frequent
young
children
presenc
viral
nucleic
acid
may
alway
reflect
associ
infecti
viru
product
limit
like
hold
true
newborn
well
reflect
find
show
respiratori
pathogen
detect
neonat
without
respiratori
symptom
addit
blood
cultur
remain
neg
three
children
nasopharyng
aspir
test
posit
pneumonia
rtpcr
studi
asymptomat
colon
specif
bacteri
pathogen
demonstr
bisgaard
et
al
neonat
born
mother
asthma
gener
ct
valu
may
help
differenti
symptomat
asymptomat
infect
data
show
neonat
respiratori
sampl
test
posit
contain
lower
ct
level
ie
higher
viral
load
inde
often
clinic
ill
neonat
low
viral
load
regardless
studi
design
realli
allow
us
draw
conclus
regard
asymptomat
carriership
neonat
popul
hospit
therefor
true
asymptomat
comparison
group
compar
demograph
clinic
characterist
neonat
posit
rtpcr
studi
pathogen
neg
rtpcr
result
found
seven
variabl
show
statist
signific
differ
therefor
potenti
associ
risk
posit
rtpcr
result
respiratori
pathogen
age
late
newborn
admiss
first
gravid
preterm
deliveri
epidur
anesthesia
rhinorrhea
wheez
adjust
confound
age
day
older
confid
interv
rhinorrhea
confid
interv
remain
signific
contributor
increas
risk
rtpcr
posit
studi
pathogen
risk
factor
infect
thoroughli
character
rsv
prematur
young
age
shown
independ
risk
factor
rsvassoci
hospit
birth
onset
rsv
season
environment
factor
presenc
schoolag
sibl
day
care
attend
also
design
signific
risk
factor
sever
rsv
infect
similar
result
unadjust
univari
analysi
studi
newborn
infect
rang
respiratori
virus
compar
newborn
without
infect
show
wheez
one
symptom
significantli
frequent
notic
presenc
respiratori
viru
infect
neonat
nonspecif
syndrom
infect
unknown
origin
current
guidelin
use
respiratori
pathogen
diagnost
clinic
practic
case
usual
regard
possibl
sepsi
collect
blood
sampl
bacteri
cultur
empir
antibiot
initi
conform
guidelin
howev
antibiot
neonat
infect
especi
frequent
use
aminoglycosid
lead
seriou
toxic
addit
costeffect
studi
shown
treatment
children
age
mo
lower
respiratori
tract
infect
caus
consider
econom
burden
part
caus
durat
hospit
studi
valu
rtpcr
diagnost
children
shown
conflict
result
whether
introduct
method
diagnost
tool
neonat
infect
might
benefit
result
studi
pediatrician
blind
rtpcr
result
show
median
durat
clinic
admiss
shorter
among
neonat
posit
result
nonsignific
differ
p
variabl
relat
clinic
cours
outcom
compar
two
group
therefor
neonat
hospit
nonspecif
sign
symptom
possibl
advantag
perform
rtpcr
assay
detect
respiratori
pathogen
remain
elucid
note
show
posit
blood
cultur
consid
ultim
proof
bacteri
infect
seen
among
neonat
nasopharyng
aspir
posit
respiratori
pathogen
detect
rtpcr
might
cautiou
argument
support
withhold
antibiot
decreas
use
respiratori
virus
etiolog
agent
detect
use
rtpcr
assay
respiratori
sampl
limit
studi
need
discuss
first
although
first
describ
neonat
popul
medium
care
set
restrict
milder
case
compar
neonat
admit
intens
care
set
would
interest
use
repeat
research
among
unselect
neonat
hospit
irrespect
intens
provid
care
anoth
limit
identifi
neonat
respiratori
pathogen
even
though
compris
total
popul
absolut
number
use
analys
rel
small
especi
consid
detect
pathogen
separ
increas
power
detect
relev
differ
group
longer
followup
period
would
ad
valu
last
limit
studi
design
yet
allow
us
draw
solid
conclus
use
rtpcr
therefor
role
clinic
practic
random
control
trial
would
give
us
definit
answer
